Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry-Reference-Cited by-同舟云学术

Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry

Published:2004-07-28 Issue:2 Volume:21 Page:143-149
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab. Res. Rev.

Author:

Danchin Nicolas,Charpentier Guillaume,Ledru François,Vaur Laurent,Guéret Pascal,Hanania Guy,Blanchard Didier,Lablanche Jean-Marc,Genès Nathalie,Cambou Jean-Pierre

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference27 articles.

1. Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration;Engler;Circulation,1996

2. The sulfonylurea controversy: more questions from the heart;Brady;J Am Coll Cardiol,1998

3. Oral sulfonylurea hypoglycaemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited;Cleveland;Circulation,1997

4. Sulfonylureas and ischaemic preconditioning. A double-blind, placebo-controlled evaluation of glimepiride and glibenclamide;Klepzig;Eur Heart J,1999

5. A summary of criticisms of the findings and conclusions of the university group diabetes program (UGDP);Seltzer;Diabetes,1972

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes;Cardiovascular Research;2024-07-19

2. Management of Type 2 DiabetesMellitus;Type 2 Diabetes - From Diagnosis to Effective Management [Working Title];2023-09-27

3. Sulfonylureas and the Risk of Ventricular Arrhythmias Among People with Type 2 Diabetes: A Systematic Review of Observational Studies;Clinical Pharmacology & Therapeutics;2022-03-22

4. The mechanism of mulberry leaves against renal tubular interstitial fibrosis through ERK1/2 signaling pathway was predicted by network pharmacology and validated in human tubular epithelial cells;Phytotherapy Research;2019-06-17

5. Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence;Trends in Endocrinology & Metabolism;2017-08